Page last updated: 2024-10-17

aminocaproic acid and Epistaxis

aminocaproic acid has been researched along with Epistaxis in 7 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Epistaxis: Bleeding from the nose.

Research Excerpts

ExcerptRelevanceReference
" A combination of aprotinin with tranexamic acid may be effective in preventing or delaying rebleeding after rupture of an intracerebral aneurysm; the addition of aprotinin seems to decrease the incidence of delayed cerebral vasospasm and ischaemic complications which are sometimes noted when tranexamic acid alone is used."4.77Clinical application of inhibitors of fibrinolysis. ( Verstraete, M, 1985)
"Acquired factor VIII deficiency is a rare immunologic disorder characterized by severe bleeding due to an antibody inhibitor directed against factor VIII."1.28Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency. ( Lalwani, RB; Stricker, RB, 1992)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melia, L1
McGarry, G1
Mikhail, S1
Kouides, P1
KUROZAWA, T1
SVENNINGSEN, NW1
Ozelo, MC1
Svirin, P1
Larina, L1
Lalwani, RB1
Stricker, RB1
Verstraete, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599]40 participants (Actual)Interventional2011-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for aminocaproic acid and Epistaxis

ArticleYear
Epistaxis in adults: a clinical review.
    British journal of hospital medicine (London, England : 2005), 2008, Volume: 69, Issue:7

    Topics: Adult; Age Factors; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Embolization, Therapeutic; Eme

2008
Clinical application of inhibitors of fibrinolysis.
    Drugs, 1985, Volume: 29, Issue:3

    Topics: 4-Aminobenzoic Acid; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Aprotinin; Blood Preser

1985

Other Studies

5 other studies available for aminocaproic acid and Epistaxis

ArticleYear
von Willebrand disease in the pediatric and adolescent population.
    Journal of pediatric and adolescent gynecology, 2010, Volume: 23, Issue:6 Suppl

    Topics: Adolescent; Aminocaproic Acid; Antifibrinolytic Agents; Child; Contusions; Deamino Arginine Vasopres

2010
[CASE OF TREATMENT OF EPISTAXIS WITH IPSILON CAUSING SUDDEN SYMPTOMS OF SHOCK].
    Jibi inkoka Otolaryngology, 1963, Volume: 35

    Topics: Adolescent; Aminocaproates; Aminocaproic Acid; Drug Hypersensitivity; Epistaxis; Shock; Shock, Septi

1963
THROMBOCYTOPENIA AFTER RUBELLA (REPORT OF TWO CASES).
    Acta paediatrica Scandinavica, 1965, Volume: 54

    Topics: Aminocaproates; Aminocaproic Acid; Child; Drug Therapy; Epistaxis; Hematuria; Humans; Pathology; Pre

1965
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Annals of hematology, 2005, Volume: 84, Issue:12

    Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Bernard-Soulier Syndrome; Epistaxis;

2005
Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
    The American journal of the medical sciences, 1992, Volume: 303, Issue:6

    Topics: Aged; Aminocaproic Acid; Epistaxis; Factor VIII; Hemophilia A; Humans; Male

1992